Toshiaki Okada
Fukuyama, 7208520, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Tezepelumab in severe asthma with pulmonary mucus plugs and eosinophilic chronic rhinosinusitis after dupilumab intolerance and suboptimal mepolizumab response: A case report.
Journal: Respiratory medicine case reports
Published: February 12, 2026
Lung Adenocarcinoma Developing Pleomorphic Carcinoma With ERBB3 Amplification After Acquired Resistance to Sotorasib: A Case Report.
Journal: JTO clinical and research reports
Published: January 20, 2026
A Rare Presentation of Pneumonic-Type Adenocarcinoma Hidden behind Empyema.
Journal: Acta medica Okayama
Published: August 27, 2025
Effect of a Cyclooxygenase-2 Inhibitor in Combination with (-)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice.
Journal: Acta medica Okayama
Published: February 27, 2023
Diffuse large B-cell lymphoma in the course of systemic sarcoidosis: A case report and review of 30 Japanese patients with sarcoidosis-lymphoma syndrome.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: September 28, 2022
Anti-SOX1 Antibody-positive Small-cell Lung Cancer That Triggered Opsoclonus.
Journal: Internal medicine (Tokyo, Japan)
Published: August 21, 2022
Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer.
Journal: Journal of pharmaceutical health care and sciences
Published: April 27, 2022
Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir.
Journal: Clinical case reports
Published: May 08, 2021
A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 23, 2017
A phase II study of topotecan and cisplatin with sequential thoracic radiotherapy in elderly patients with small-cell lung cancer: Okayama Lung Cancer Study Group 0102.
Journal: Cancer chemotherapy and pharmacology
Published: June 16, 2016
Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience.
Journal: Cancer chemotherapy and pharmacology
Published: August 31, 2015
Last Updated: 09/26/2026